The MAMA-MIA Challenge: Advancing Generalizability and Fairness in Breast MRI Tumor Segmentation and Treatment Response Prediction

• URL: http://arxiv.org/abs/2603.01250v1
• Date: Sun, 01 Mar 2026 20:06:30 GMT
• Title: The MAMA-MIA Challenge: Advancing Generalizability and Fairness in Breast MRI Tumor Segmentation and Treatment Response Prediction
• Authors: Lidia Garrucho, Smriti Joshi, Kaisar Kushibar, Richard Osuala, Maciej Bobowicz, Xavier Bargalló, Paulius Jaruševičius, Kai Geissler, Raphael Schäfer, Muhammad Alberb, Tony Xu, Anne Martel, Daniel Sleiman, Navchetan Awasthi, Hadeel Awwad, Joan C. Vilanova, Robert Martí, Daan Schouten, Jeong Hoon Lee, Mirabela Rusu, Eleonora Poeta, Luisa Vargas, Eliana Pastor, Maria A. Zuluaga, Jessica Kächele, Dimitrios Bounias, Alexandra Ertl, Katarzyna Gwoździewicz, Maria-Laura Cosaka, Pasant M. Abo-Elhoda, Sara W. Tantawy, Shorouq S. Sakrana, Norhan O. Shawky-Abdelfatah, Amr Muhammad Abdo-Salem, Androniki Kozana, Eugen Divjak, Gordana Ivanac, Katerina Nikiforaki, Michail E. Klontzas, Rosa García-Dosdá, Meltem Gulsun-Akpinar, Oğuz Lafcı, Carlos Martín-Isla, Oliver Díaz, Laura Igual, Karim Lekadir,
• Abstract summary: The MAMA-MIA Challenge aims to develop a large-scale benchmark that jointly evaluates primary tumor segmentation and prediction of pathologic complete response.<n>The training cohort comprised 1,506 patients from multiple institutions in the United States, while evaluation was conducted on an external test set of 574 patients from three independent European centers.<n>Results demonstrate substantial performance variability under external testing and reveal trade-offs between overall accuracy and subgroup fairness.
• Score: 26.87720191540453
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: Breast cancer is the most frequently diagnosed malignancy among women worldwide and a leading cause of cancer-related mortality. Dynamic contrast-enhanced magnetic resonance imaging plays a central role in tumor characterization and treatment monitoring, particularly in patients receiving neoadjuvant chemotherapy. However, existing artificial intelligence models for breast magnetic resonance imaging are often developed using single-center data and evaluated using aggregate performance metrics, limiting their generalizability and obscuring potential performance disparities across demographic subgroups. The MAMA-MIA Challenge was designed to address these limitations by introducing a large-scale benchmark that jointly evaluates primary tumor segmentation and prediction of pathologic complete response using pre-treatment magnetic resonance imaging only. The training cohort comprised 1,506 patients from multiple institutions in the United States, while evaluation was conducted on an external test set of 574 patients from three independent European centers to assess cross-continental and cross-institutional generalization. A unified scoring framework combined predictive performance with subgroup consistency across age, menopausal status, and breast density. Twenty-six international teams participated in the final evaluation phase. Results demonstrate substantial performance variability under external testing and reveal trade-offs between overall accuracy and subgroup fairness. The challenge provides standardized datasets, evaluation protocols, and public resources to promote the development of robust and equitable artificial intelligence systems for breast cancer imaging.

Related papers

• Beyond Benchmarks of IUGC: Rethinking Requirements of Deep Learning Methods for Intrapartum Ultrasound Biometry from Fetal Ultrasound Videos [58.71502465551297]
  Intrapartum Ultrasound Grand Challenge (IUGC) co-hosted with MICCAI 2024 was launched.<n>IUGC introduces a clinically oriented multi-task automatic measurement framework that integrates standard plane classification, fetal head-pubic symphysis segmentation, and biometry.<n>The challenge releases the largest multi-center intrapartum ultrasound video dataset to date, comprising 774 videos (68,106 frames) collected from three hospitals.
  arXiv  Detail & Related papers  (2026-02-13T13:28:22Z)
• Mammo-FM: Breast-specific foundational model for Integrated Mammographic Diagnosis, Prognosis, and Reporting [10.376219551996792]
  Mammo-FM is the first foundation model specifically for mammography, pretrained on the largest and most diverse dataset to date.<n>Mammo-FM provides a unified foundation for core clinical tasks in breast imaging, including cancer diagnosis, pathology localization, structured report generation, and cancer risk prognosis within a single framework.
  arXiv  Detail & Related papers  (2025-11-28T20:41:14Z)
• An Explainable Hybrid AI Framework for Enhanced Tuberculosis and Symptom Detection [55.35661671061754]
  Tuberculosis remains a critical global health issue, particularly in resource-limited and remote areas.<n>We propose a framework which enhances disease and symptom detection on chest X-rays by integrating two supervised heads and a self-supervised head.<n>Our model achieves an accuracy of 98.85% for distinguishing between COVID-19, tuberculosis, and normal cases, and a macro-F1 score of 90.09% for multilabel symptom detection.
  arXiv  Detail & Related papers  (2025-10-21T17:18:55Z)
• Enhancing Trust in Clinically Significant Prostate Cancer Prediction with Multiple Magnetic Resonance Imaging Modalities [61.36288157482697]
  In the United States, prostate cancer is the second leading cause of deaths in males with a predicted 35,250 deaths in 2024. In this paper, we investigate combining multiple MRI modalities to train a deep learning model to enhance trust in the models for clinically significant prostate cancer prediction.
  arXiv  Detail & Related papers  (2024-11-07T12:48:27Z)
• A Large Model for Non-invasive and Personalized Management of Breast Cancer from Multiparametric MRI [19.252851972152957]
  We develop a large mixture-of-modality-experts model (MOME) that integrates multi-parametric MRI information within a unified structure.<n>MOME matches four senior radiologists' performance in identifying breast cancer and outperforms a junior radiologist.
  arXiv  Detail & Related papers  (2024-08-08T05:04:13Z)
• Analysis of the 2024 BraTS Meningioma Radiotherapy Planning Automated Segmentation Challenge [45.3253187215396]
  The 2024 Brain Tumor Meningioma Radiotherapy (BraTS-MEN-RT) challenge aimed to advance automated segmentation algorithms.<n>We describe the design and results from the BraTS-MEN-RT challenge.
  arXiv  Detail & Related papers  (2024-05-28T17:25:43Z)
• The 2024 Brain Tumor Segmentation (BraTS) Challenge: Glioma Segmentation on Post-treatment MRI [5.725734864357991]
  The 2024 Brain Tumor (BraTS) challenge on post-treatment glioma MRI will provide a community standard and benchmark for state-of-the-art automated segmentation models. Challenge competitors will develop automated segmentation models to predict four distinct tumor sub-regions. Models will be evaluated on separate validation and test datasets.
  arXiv  Detail & Related papers  (2024-05-28T17:07:55Z)
• Using Multiparametric MRI with Optimized Synthetic Correlated Diffusion Imaging to Enhance Breast Cancer Pathologic Complete Response Prediction [71.91773485443125]
  Neoadjuvant chemotherapy has recently gained popularity as a promising treatment strategy for breast cancer. The current process to recommend neoadjuvant chemotherapy relies on the subjective evaluation of medical experts. This research investigates the application of optimized CDI$s$ to enhance breast cancer pathologic complete response prediction.
  arXiv  Detail & Related papers  (2024-05-13T15:40:56Z)
• The ASNR-MICCAI Brain Tumor Segmentation (BraTS) Challenge 2023: Intracranial Meningioma [4.435336201147607]
  The BraTS meningioma 2023 challenge will provide a community standard and benchmark for state-of-the-art automated intracranial meningioma segmentation models. Challenge competitors will develop automated segmentation models to predict three distinct meningioma sub-regions on MRI.
  arXiv  Detail & Related papers  (2023-05-12T17:52:36Z)
• Exploiting segmentation labels and representation learning to forecast therapy response of PDAC patients [60.78505216352878]
  We propose a hybrid deep neural network pipeline to predict tumour response to initial chemotherapy. We leverage a combination of representation transfer from segmentation to classification, as well as localisation and representation learning. Our approach yields a remarkably data-efficient method able to predict treatment response with a ROC-AUC of 63.7% using only 477 datasets in total.
  arXiv  Detail & Related papers  (2022-11-08T11:50:31Z)
• MyoPS: A Benchmark of Myocardial Pathology Segmentation Combining Three-Sequence Cardiac Magnetic Resonance Images [84.02849948202116]
  This work defines a new task of medical image analysis, i.e., to perform myocardial pathology segmentation (MyoPS) MyoPS combines three-sequence cardiac magnetic resonance (CMR) images, which was first proposed in the MyoPS challenge, in conjunction with MICCAI 2020. The challenge provided 45 paired and pre-aligned CMR images, allowing algorithms to combine the complementary information from the three CMR sequences for pathology segmentation.
  arXiv  Detail & Related papers  (2022-01-10T06:37:23Z)
• Lung-Originated Tumor Segmentation from Computed Tomography Scan (LOTUS) Benchmark [48.30502612686276]
  Lung cancer is one of the deadliest cancers, and its effective diagnosis and treatment depend on the accurate delineation of the tumor. Human-centered segmentation, which is currently the most common approach, is subject to inter-observer variability. The 2018 VIP Cup started with a global engagement from 42 countries to access the competition data. In a nutshell, all the algorithms proposed during the competition, are based on deep learning models combined with a false positive reduction technique.
  arXiv  Detail & Related papers  (2022-01-03T03:06:38Z)
• The Brain Tumor Sequence Registration (BraTS-Reg) Challenge: Establishing Correspondence Between Pre-Operative and Follow-up MRI Scans of Diffuse Glioma Patients [31.567542945171834]
  We describe the Brain Tumor Sequence Registration (BraTS-Reg) challenge. BraTS-Reg is the first public benchmark environment for deformable registration algorithms. The aim of BraTS-Reg is to continue to serve as an active resource for research.
  arXiv  Detail & Related papers  (2021-12-13T19:25:16Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.